What is the treatment for urethritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Urethritis

For confirmed urethritis, initiate empiric dual therapy immediately with Ceftriaxone 250-500 mg IM single dose PLUS Doxycycline 100 mg orally twice daily for 7 days to cover both gonorrhea and chlamydia. 1

Confirming the Diagnosis Before Treatment

Before initiating therapy, document urethritis using at least one of these objective criteria: 2, 1

  • Mucopurulent or purulent urethral discharge (visible on examination) 2
  • Gram stain of urethral secretions showing ≥5 WBCs per oil immersion field (preferred rapid diagnostic test) 2
  • Positive leukocyte esterase test on first-void urine 2
  • Microscopic examination of first-void urine showing ≥10 WBCs per high-power field 2

If none of these criteria are present, defer treatment and test for N. gonorrhoeae and C. trachomatis using nucleic acid amplification tests, then follow closely. 2, 3

When to Treat Empirically Without Confirmed Urethritis

The only exception: Treat empirically without documentation of urethritis for high-risk patients unlikely to return for follow-up (e.g., adolescents with multiple partners). 2, 3 These patients should receive dual coverage for both gonorrhea and chlamydia. 2

First-Line Treatment Regimens

Dual Therapy (Preferred for Empiric Treatment)

Ceftriaxone 250-500 mg IM single dose PLUS Doxycycline 100 mg orally twice daily for 7 days 1

This dual regimen is essential because: 1

  • Most sexually transmitted urethritis in men under 35 is caused by C. trachomatis or N. gonorrhoeae 1
  • Co-infection with both pathogens is common 1
  • Delaying treatment increases risk of complications (epididymitis) and ongoing transmission 1

Alternative Regimens for Nongonococcal Urethritis (If Gonorrhea Ruled Out)

Recommended: 2, 1

  • Azithromycin 1 g orally single dose (advantage: single-dose ensures compliance, particularly effective against M. genitalium) 2, 4
  • OR Doxycycline 100 mg orally twice daily for 7 days (highly effective for chlamydial urethritis) 2

Alternative regimens if first-line options contraindicated: 2

  • Erythromycin base 500 mg orally four times daily for 7 days 2
  • Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 2
  • Ofloxacin 300 mg orally twice daily for 7 days 2
  • Levofloxacin 500 mg orally once daily for 7 days 2

Critical Management Steps

Testing Requirements

  • All patients with confirmed or suspected urethritis must be tested for both gonorrhea and chlamydia using nucleic acid amplification tests 2, 1
  • Perform HIV and syphilis testing as part of comprehensive STI screening 1, 3
  • Testing for chlamydia is strongly recommended because specific diagnosis enhances partner notification and compliance 2

Partner Management

  • Refer all sexual partners within the preceding 60 days for evaluation and treatment 2, 1
  • Partners should receive treatment effective against chlamydia regardless of whether a specific pathogen is identified in the index patient 1, 3
  • Both patient and all partners must abstain from sexual intercourse until 7 days after therapy initiation AND symptom resolution 2, 1

Follow-Up

  • Patients should return only if symptoms persist or recur after completing therapy 2
  • Symptoms alone without objective signs of urethritis are NOT sufficient basis for re-treatment 2
  • Consider repeat testing 3-6 months after treatment due to high reinfection rates 3
  • Test-of-cure is not recommended for asymptomatic patients who received recommended treatment 5

Management of Persistent or Recurrent Urethritis

Objective signs of urethritis must be present before initiating additional antimicrobial therapy. 2

Re-treatment Algorithm:

  1. If patient did not comply with initial regimen OR was re-exposed to untreated partner: Re-treat with the initial regimen 2

  2. If patient was compliant and re-exposure excluded: 2

    • Perform culture for T. vaginalis 2
    • Consider tetracycline-resistant U. urealyticum 2
    • Recommended regimen for persistent/recurrent urethritis: 2
      • Metronidazole 2 g orally single dose PLUS
      • Erythromycin base 500 mg orally four times daily for 7 days OR Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days
  3. If symptoms persist beyond 3 months: Consider chronic prostatitis/chronic pelvic pain syndrome 2

Common Pitfalls to Avoid

  • Never treat for gonorrhea alone without chlamydia coverage – co-infection is extremely common 1
  • Do not treat based on symptoms alone without objective evidence of urethritis unless patient meets high-risk criteria for empiric treatment 3
  • Do not forget that antimicrobials used for urethritis may mask or delay symptoms of incubating syphilis – all patients with sexually transmitted urethritis must have serologic testing for syphilis 4
  • Failure to improve within 3 days requires diagnostic re-evaluation 1
  • Do not rely on semen analysis to diagnose urethritis – use proper urethral testing criteria 5

Special Considerations

HIV-Positive Patients

Patients with urethritis who are also HIV-positive should receive the same treatment regimen as HIV-negative patients. 2, 1 Gonococcal and chlamydial urethritis may facilitate HIV transmission. 2

Medication Provision

To improve compliance, medication should ideally be provided directly in the clinic or healthcare provider's office, allowing for directly observed therapy with single-dose regimens. 2

References

Guideline

Empiric Antibiotic Therapy for Suspected Urethritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Urethritis with Symptoms but Absent White Blood Cells on First-Void Urine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Urethritis with Symptoms but No Leukocytospermia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.